than 30 tablets or capsules for the treatment of dysmenorrhoea 104 Mepyramine; for dermal use 105 Mercuric oxide; for ophthalmic use 106 Mercury; for external use in medicines containing 0.5% or less 107 Methoxamine; for external use in medicines containing more than 1% 108 Methoxyphenamine 109 Methylephedrine 110 Miconazole; for external use except in medicines for tinea pedis only 111 Minoxidil; for dermal use in medicines containing 5% or less 112 Mometasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age when in aqueous nasal sprays delivering up to 50 micrograms per actuation and when the maximum recommended daily dose is no greater than 200 micrograms and the medicine has received the consent of the Minister or the Director-General to its distribution as a pharmacy-only medicine 113 Morphine; in medicines for oral use containing not more than 0.2% of morphine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine 114 Naphazoline; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board 115 Naproxen; in solid dose form containing 250 milligrams or less per dose form in packs of not more than 30 tablets or capsules 116 Niclosamide 117 Nicotine; for inhalation